INTRODUCTION
The endocrine mechanisms controlling the initiation of labour in the human have not yet been fully identified.
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The neurohypophyseal hormone, oxytocin, causes contraction of smooth muscle in the uterus and has also been used widely to induce and augment labour. The role of oxytocin, if any, in the onset of labour is not clear ; however, a description of the control mechanisms involved in oxytocin secretion may give valuable insight into its relative importance.
Maternal oxytocin has been found to have a pulsatile release which demonstrates a greater frequency after the onset of labour than before labour [1] . During pregnancy oxytocin levels in the maternal circulation have been found to rise towards term [2] [3] [4] and subsequently rise in the second stage of labour [5] .
Additionally, the fetus may have a regulatory role in initiation of the labour process as the fetus itself produces oxytocin. Umbilical artery oxytocin levels have been found to be higher in patients who have had either a vaginal delivery or a Caesarean section in labour compared with patients who have had elective Caesarean sections [4, 6, 7] . It is notable that the umbilical artery oxytocin levels are significantly higher than the umbilical vein levels [4, 5, 7] , suggesting that the oxytocin present in the fetal circulation has been produced by the fetus.
Oxytocin production has been shown to be under the inhibitory control of endogenous opioids in animal experiments [8] . In human pregnancy maternal oxytocin levels are reduced by exogenous opiate administration in the first stage of labour [9] , thus suggesting a possible inhibitory control mechanism involving endogenous opiates. It is possible that a similar opiate interaction may be a regulatory mechanism for oxytocin production in the fetus as well as the mother.
This study was designed to investigate the effects of exogenous opiates administered to the mother on the fetal oxytocin concentration in labour.
METHODS
Permission to perform this study was granted by the Ethics and Research Committee of the University of Cape Town Medical School. All patients gave their informed written consent before participation in the study. Morphine is an opiate analgesic which is routinely prescribed to patients in labour in the Maternity Services in Cape Town.
After normal vaginal delivery and clamping of the cord, blood was aspirated from the umbilical artery and umbilical vein of the placenta before its separation from the uterus. Before separation of the placenta a maternal venous sample of blood was also obtained. Blood from the umbilical artery, umbilical vein and maternal circulation was collected into chilled tubes containing phenanthrolene [100 µl of a 2.5% (w\v) solution] and 0.05 mmol\l [0.2 % (w\v)] edetic acid, giving a concentration of 0.5 mg phenanthrolene\ml of whole blood. Samples were centrifuged immediately after collection and plasma was aspirated, flash-frozen in liquid nitrogen and stored at k20 mC [10] . The samples were subsequently assayed for oxytocin concentration by radioimmunoassay as described by Lindow et al. [9] . At the same time as the oxytocin specimens were collected a specimen of blood was aspirated from the umbilical vein and this was analysed for the concentration of morphine.
A second group of patients who underwent Caesarean section were studied ; after delivery of the fetus and cord clamping before separation of the placenta, umbilical artery and vein blood specimens were collected and a maternal venous specimen was taken simultaneously. The specimens were treated as described above.
In all cases oxytocin had not been administered either in the first, second or third stages of labour before the collection of the specimens.
Statistical analysis was performed on a minitab statistical package using analysis of variance after logarithmic transformation of data or using correlation coefficients.
MORPHINE ASSAY
Morphine was measured in the serum samples using the Coat-A-Count radioimmunoassay kit from Diagnostic Products Corporation, Catalogue No TKSM1. The recommended assay protocol utilizes the principles of solid-phase immobilized-antibody-coated tube radioimmunoassay methodology with "#&I-labelled morphine as the tracer, and was strictly adhered to. The assay tubes were counted in a Packard ' Crystal ' multiwell γ-scintillation counter. The data was subjected to the built-in data reduction facility using the four-parameter logistic fit to calculate the results which were expressed in nmol\l. The minimum detectable dose in the assay was 5 nmol\l. The coefficient of variation of the assay duplicates was 5.3 % ; all the samples in the study were run in a single batch and the within-assay coefficient of variation over the whole range of the assay was 6.8 %.
RESULTS
Four groups of patients were studied : 1. Women after a normal vaginal delivery without analgesia in labour (n l 10). 2. Women after a normal vaginal delivery who had morphine administration in the first stage of labour (n l 12). 3. Women who had an emergency Caesarean section in the first stage of labour (n l 11). 4. Women who had an elective Caesarean section at term who were not in labour (n l 11). The general characteristics of the patients are listed in Table 1 ; there were no differences between the groups.
In each of the four groups of patients the umbilical artery specimens demonstrated higher levels of oxytocin than the umbilical vein specimens. Therefore, to obtain a representation of fetal oxytocin production the umbilical artery minus the umbilical vein oxytocin level was calculated (AkV) ( Table 2 ). After logarithmic transformation the value log (A)klog (V) (equivalent to log A\V) umbilical oxytocin was used. There was no difference between the log oxytocin (A\V) values of any of the four groups of patients (F l 0.51) When the maternal oxytocin levels are considered there were no significant changes in log maternal oxytocin levels of any of the four groups (F l 2.6, P l 0.07, not significant).
When the log umbilical (A\V) oxytocin concentration in group 2 patients is compared with the log morphine concentration in the umbilical vein there is no significant correlation (correlation coefficient k0.1, P l 0.6, not significant) (Figure 1) .
Analysis of the patients who had a Caesarean section in the first stage of labour revealed the log umbilical (A\V) oxytocin level does not correlate with the log umbilical vein morphine level (correlation coefficient k0.33, P l 0.5, not significant) (Figure 1 ).
In summary, there was no change in the log umbilical (A\V) concentration of oxytocin if morphine had been given to the mother in labour ; this applied to fetuses delivered vaginally or by Caesarean section. If the fetuses who were exposed to morphine were analysed separately, there was no correlation between the log umbilical vein morphine concentration and the log umbilical (A\V) oxytocin concentration either in Caesarean or vaginal deliveries.
DISCUSSION
This is a first report on the quantification of fetal oxytocin levels in association with morphine administration to women in labour. Morphine has been shown to suppress maternal concentrations of oxytocin in the first stage of labour [9] but not before labour [11] . Levels of oxytocin found in the fetal circulation when morphine had been administered in labour were not significantly differenct from the levels noted in women who delivered without analgesia. Additionally, fetal oxytocin levels in women who had been given morphine in the first stage of labour and subsequently had a Caesarean section were not found to be significantly different from those levels found at elective Caesarean section. Secondary correlations between the concentration of morphine in the umbilical vein specimen and the (AkV) oxytocin concentrations in the emergency Caesarean section group and the group who had normal vaginal deliveries after morphine administration were not significant. It appears that fetal oxytocin production, either in the first stage or the second stage of labour, is not affected by maternal morphine administration.
Thornton et al. [12] noted that fetal production of oxytocin was not affected by pethidine analgesia ; however, they did not document the level of the opiate in the fetal circulation and there may have been considerable variation in placental transfer between patients and also the pethidine effects may have worn off due to a long administration-delivery interval. In our study, umbilical vein morphine concentrations provided quantitative evidence of morphine presence in the fetal circulation. Pethidine has been noted to be a µ receptor agonist but of low affinity and potency [13] and thus the absence of any effects on oxytocin production may not be duplicated with morphine administration which is a much more potent µ receptor agonist.
The large difference between umbilical artery and venous oxytocin concentrations has been found by many authors and is evidence of fetal oxytocin production. The role of fetal oxytocin production is not clear and it has not been established whether transplacental transfer occurs. Padayachi et al. [3] and Dawood et al. [7] noted that there is an increase in umbilical vein concentrations of oxytocin after maternal infusions of oxytocin, and in Dawood's study the umbilical vein concentration exceeded that in the artery. In contrast, Otsuki et al. [14] did not demonstrate significant levels of oxytocin in the fetal circulation in anencephalic pregnancies despite normal maternal levels.
Fetal oxytocin may exert an effect on the labour process by diffusion from the amniotic fluid to the myometrium and transfer across the placenta may not be physiologically relevant. Chibbar et al. [15] described the synthesis of oxytocin in amnion, chorion and decidua which increases around the time of labour onset ; thus the effect on the myometrium may not be primarily related to either maternal or fetal circulating oxytocin. Evidence for a maturation of fetal oxytocin production comes from studies on extended forms of oxytocin [16] which are found in umbilical artery and vein samples. The ratio of extended oxytocin and mature oxytocin is lower in fetuses who have laboured normally and delivered vaginally compared with elective Caesarean deliveries. This finding indicates that the fetus is capable of producing an active form of oxytocin when labour begins spontaneously and therefore suggests that the fetus plays a role in the initiation of labour.
There is an extensive body of literature supporting maternal oxytocin\opiate interactions in animals in labour [17] , lactation [18] and late gestation [19] , and also in humans in labour [9] . The fetal situation is less well studied and the present study does not indicate an opiatebased control mechanism for fetal oxytocin production.
The reduction in oxytocin levels in umbilical artery and vein specimens (but not in AkV levels) in elective Caesarean section patients is evidence of a change in fetal oxytocin levels but not necessarily of reduced fetal production. Thornton et al. [12] also found that when AkV fetal oxytocin levels were calculated there was no difference between pre-labour and labour situations.
In summary, we have failed to demonstrate any correlation between fetal oxytocin production and maternal morphine administration in human labour and delivery. Maternal opiate\oxytocin interactions could not be duplicated in the fetus and details of fetal oxytocin control mechanisms remain unknown.
